US Stock MarketDetailed Quotes

LGVN Longeveron

Watchlist
  • 2.020
  • +0.020+1.00%
Trading Nov 27 12:06 ET
29.97MMarket Cap-359P/E (TTM)

About Longeveron Company

Longeveron, Inc. is a clinical stage biotechnology company, which engages in the development of cellular therapies for specific aging-related and life-threatening conditions. Its lead product, LOMECEL-B, is a cell-based therapy product, which is derived from culture-expanded medicinal signaling cells that are sourced from bone marrow of young, healthy, adult donors. The company was founded by Joshua M. Hare and Donald M. Soffer on October 9, 2014 and is headquartered in Miami, FL.

Company Profile

SymbolLGVN
Company NameLongeveron
Listing DateFeb 12, 2021
Issue Price10.00
Founded2014
CEOMr. Mohamed Wael Ahmed Hashad
MarketNASDAQ
Employees25
Fiscal Year Ends12-31
AddressLife Science & Technology Park,1951 Northwest 7th Avenue,Suite 250
CityMiami
ProvinceFlorida
CountryUnited States of America
Zip Code33136
Phone1-305-909-0840
Websitehttp://www.longeveron.com

Company Executives

  • Name
  • Position
  • Salary
  • Mohamed Wael Ahmed Hashad
  • Chief Executive Officer and Director
  • 1.58M
  • Lisa Locklear
  • Treasurer, Chief Financial Officer and Principal Accounting Officer
  • 380.78K
  • Dr. Joshua M. Hare, M.D.
  • Chief Science Officer and Chairman of the Board
  • 75.31K
  • Dr. Nataliya Agafonova
  • Chief Medical Officer
  • --
  • Lisa McClain-Moss
  • Vice President, Manufacturing
  • --
  • Dr. Roger Hajjar
  • Director
  • --
  • Rock Soffer
  • Director
  • 43.81K
  • Neha Motwani
  • Director
  • --
  • Neil E. Hare
  • Director
  • 40.31K
  • Richard N. Kender, M.B.A.
  • Independent Director
  • --
  • Ursula Ungaro
  • Independent Director
  • 50.81K
  • Khoso Baluch
  • Independent Director
  • 35.97K
  • Paul Lehr
  • General Counsel and Secretary
  • 554.06K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data